CITR CitroTech Inc.
Price Chart
Executive Summary
CitroTech entered into stock exchange agreements with BoltRock Holdings and TC Special Investments to reacquire all 1,666,667 outstanding shares of Series A Preferred Stock in exchange for 570,570 shares of newly issued Series C Convertible Preferred Stock. The transactions eliminate the Series A overhang, provide the holders with board designation/observer rights while they remain 10% holders, and include registration rights and, for BRH, limited consent rights for 12 months. TCSI's shares are deferred for 18 months unless a change of control occurs.
Actionable Insight
The recapitalization simplifies the capital structure by removing the Series A Preferred overhang, but the conversion terms of the new Series C shares are undisclosed — monitor for a subsequent filing detailing conversion ratio and liquidation preference. The 18-month deferral on TCSI's shares and the lock-up on BRH's shares limit near-term selling pressure, but the registration rights granted could lead to future dilution once the lock-up expires.
Key Facts
- CitroTech reacquired all 1,666,667 outstanding shares of Series A Preferred Stock.
- Issued 103,558 shares of Series C Convertible Preferred to BoltRock Holdings at closing.
- Agreed to issue 467,012 shares of Series C Convertible Preferred to TC Special Investments in 18 months (or earlier upon a change of control).
- No shares of Series A Preferred Stock remain outstanding after the exchange.
- Holders get board designation/observer rights while they remain 10% holders.
- BRH has limited consent rights over C-suite hiring/firing and related-party transactions for 12 months.
- BRH shares are locked up for 18 months; TCSI shares are deferred for 18 months.
- The exchange was structured as a tax-free recapitalization under Section 368(a)(1)(E).
Financial Impact
Elimination of all Series A Preferred Stock (1,666,667 shares) in exchange for 570,570 shares of Series C Convertible Preferred. No cash consideration. The Series C conversion terms and economic preferences are not disclosed, so the net impact on common equity is unclear.
Risk Factors
- Conversion terms of Series C Preferred are not disclosed — could be significantly dilutive to common equity.
- TCSI's deferred issuance accelerates upon a change of control, including the appointment of Theodore S. Ralston to the board, creating a potential overhang catalyst.
- Registration rights allow holders to register their shares for resale, increasing future dilution risk.
- BRH's consent rights over C-suite changes and related-party transactions could constrain management flexibility for 12 months.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-004423 |
| Document: citro_ex1002.htm | 0001683168-26-004423 |
| Document: citro_8k.htm | 0001683168-26-004423 |
| Document: 0001683168-26-004423-index-headers.html | 0001683168-26-004423 |
| Document: 0001683168-26-004423-index.html | 0001683168-26-004423 |
| Document: 0001683168-26-004423.txt | 0001683168-26-004423 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
11d ago
|
8-K
| $6.92 $6.80 | ▼ −1.73% | ▼ −1.01% | $6.14 (−11.27%) |
|
Apr 21, 2026
7w ago
|
8-K
| $8.00 $7.99 | ▼ −0.13% | ▼ −1.14% | $6.14 (−23.25%) |
|
Apr 15, 2026
8w ago
|
EFFECT
| $8.40 $8.50 | ▼ −1.19% | ▼ −0.94% | $6.14 (+26.90%) |
|
Apr 9, 2026
9w ago
|
S-1/A
| $9.09 $9.05 | ▲ +0.44% | ▲ +0.38% | $6.14 (+32.45%) |
|
Apr 3, 2026
10w ago
|
8-K
| $9.43 $9.19 | ▼ −2.55% | ▼ −2.61% | $6.14 (−34.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access